
BioPorto
BIOPOR.COBioPorto A/S Price (BIOPOR.CO)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
358,498,000
(8.2416)%Description
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tests and tools, and antibodies for clinicians and researchers in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. The company was... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $1.21-2.85
- Market Cap 616.13M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Diagnostics & Research
- ceo: Mr. Peter Moerch Eriksen B.B.A., BBA
- IPO Date: January, 13, 2000
- Country: DK
- Currency: DKK
- Headquaters: No Data
- Employees: 36
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
